Firstfollowers

Audits
2
Findings
50
Total Expended
$1.85M
Latest Accepted
2025-05-08
Location: Champaign, IL
UEI: XBZEPBACJKA5 EIN: 475633240

SAM.gov Exclusion Status:

Checking exclusion status...

Audits by Year

  • 2023 1
  • 2024 1

Top Programs

By expenditures

Contacts

Name Title Type
Katie Bermingham Principal Auditee
Marlon Mitchell Executive Director Auditee
Dawn M. Carlson Signing Director Auditee
No contacts on file

Recent Audits

ID Year Date Accepted Auditor Spend
355815 2024 2025-05-08 Cliftonlarsonallen LLP $1.05M
308844 2023 2024-06-14 Cliftonlarsonallen LLP $798,823

Audit Findings

Audit Year Accepted Finding Ref Severity Repeat Requirement
355815 2024 2025-05-08 1136335 2024-005 Significant Deficiency - N
355815 2024 2025-05-08 1136334 2024-004 Significant Deficiency Yes L
355815 2024 2025-05-08 1136333 2024-003 Material Weakness Yes I
355815 2024 2025-05-08 1136332 2024-002 Material Weakness Yes AB
355815 2024 2025-05-08 1136331 2024-005 Significant Deficiency - N
355815 2024 2025-05-08 1136330 2024-004 Significant Deficiency Yes L
355815 2024 2025-05-08 1136329 2024-003 Material Weakness Yes I
355815 2024 2025-05-08 1136328 2024-002 Material Weakness Yes AB
355815 2024 2025-05-08 1136327 2024-005 Significant Deficiency - N
355815 2024 2025-05-08 1136326 2024-004 Significant Deficiency Yes L
355815 2024 2025-05-08 1136325 2024-003 Material Weakness Yes I
355815 2024 2025-05-08 1136324 2024-002 Material Weakness Yes AB
355815 2024 2025-05-08 1136323 2024-005 Significant Deficiency - N
355815 2024 2025-05-08 1136322 2024-004 Significant Deficiency Yes L
355815 2024 2025-05-08 1136321 2024-003 Material Weakness Yes I
355815 2024 2025-05-08 1136320 2024-002 Material Weakness Yes AB
355815 2024 2025-05-08 559893 2024-005 Significant Deficiency - N
355815 2024 2025-05-08 559892 2024-004 Significant Deficiency Yes L
355815 2024 2025-05-08 559891 2024-003 Material Weakness Yes I
355815 2024 2025-05-08 559890 2024-002 Material Weakness Yes AB
355815 2024 2025-05-08 559889 2024-005 Significant Deficiency - N
355815 2024 2025-05-08 559888 2024-004 Significant Deficiency Yes L
355815 2024 2025-05-08 559887 2024-003 Material Weakness Yes I
355815 2024 2025-05-08 559886 2024-002 Material Weakness Yes AB
355815 2024 2025-05-08 559885 2024-005 Significant Deficiency - N
355815 2024 2025-05-08 559884 2024-004 Significant Deficiency Yes L
355815 2024 2025-05-08 559883 2024-003 Material Weakness Yes I
355815 2024 2025-05-08 559882 2024-002 Material Weakness Yes AB
355815 2024 2025-05-08 559881 2024-005 Significant Deficiency - N
355815 2024 2025-05-08 559880 2024-004 Significant Deficiency Yes L
355815 2024 2025-05-08 559879 2024-003 Material Weakness Yes I
355815 2024 2025-05-08 559878 2024-002 Material Weakness Yes AB
308844 2023 2024-06-14 977279 2023-005 Material Weakness - AB
308844 2023 2024-06-14 977278 2023-004 Material Weakness - I
308844 2023 2024-06-14 977277 2023-006 Significant Deficiency - L
308844 2023 2024-06-14 977276 2023-005 Material Weakness - AB
308844 2023 2024-06-14 977275 2023-004 Material Weakness - I
308844 2023 2024-06-14 977274 2023-005 Material Weakness - AB
308844 2023 2024-06-14 977273 2023-004 Significant Deficiency - I
308844 2023 2024-06-14 977272 2023-005 Material Weakness - AB
308844 2023 2024-06-14 977271 2023-004 Material Weakness - I
308844 2023 2024-06-14 400837 2023-005 Material Weakness - AB
308844 2023 2024-06-14 400836 2023-004 Material Weakness - I
308844 2023 2024-06-14 400835 2023-006 Significant Deficiency - L
308844 2023 2024-06-14 400834 2023-005 Material Weakness - AB
308844 2023 2024-06-14 400833 2023-004 Material Weakness - I
308844 2023 2024-06-14 400832 2023-005 Material Weakness - AB
308844 2023 2024-06-14 400831 2023-004 Significant Deficiency - I
308844 2023 2024-06-14 400830 2023-005 Material Weakness - AB
308844 2023 2024-06-14 400829 2023-004 Material Weakness - I